Aligos Therapeutics, Inc. (ALGS)

NASDAQ: ALGS · Real-Time Price · USD

6.44

-0.45 (-6.53%)

At close: Aug 20, 2026, 4:00 PM EDT

6.78

+0.34 (5.28%)

After-hours: Aug 20, 2026, 5:55 PM EDT

Aligos Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	30.38	18.3	37	135.7	81.35	186.82
Short-Term Investments	-	59.54	19.94	-	44.48	3.92
Cash & Short-Term Investments	30.38	77.84	56.94	135.7	125.83	190.73
Cash Growth	-75.29%	36.71%	-58.04%	7.85%	-34.03%	-21.67%
Restricted Cash	0.04	0.11	0.11	0.07	0.12	0.16
Other Current Assets	3.93	4.91	5.09	5.31	7.6	13.53
Total Current Assets	62.13	82.86	62.14	141.08	133.55	204.42
Property, Plant & Equipment	3.44	4.96	7.33	9.82	12.51	14.97
Long-Term Investments	-	-	-	-	-	15.11
Other Long-Term Assets	0.76	0.72	0.63	0.63	0.63	0.87
Total Assets	66.33	88.53	70.09	151.53	146.69	235.37

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	6.43	3.98	2.57	2.52	4.74	3.02
Accrued Expenses	18.7	13.53	15.56	16.84	16.04	25.39
Current Portion of Leases	3.22	3.73	3.46	3.24	3.14	2.91
Current Unearned Revenue	-	-	0.15	1.31	9.21	7.64
Total Current Liabilities	28.34	21.23	21.74	23.91	33.13	38.96
Long-Term Leases	0.29	1.53	4.92	7.9	9.43	11.55
Long-Term Unearned Revenue	-	-	-	-	0.23	-
Other Long-Term Liabilities	5.81	12.23	72.41	27.64	-	0.13
Total Liabilities	34.44	34.99	99.07	59.45	42.79	50.64

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.01	0.01	0.01	0.01	0	0
Additional Paid-In Capital	698.18	695.27	588.58	578.33	502.61	487.35
Retained Earnings	-666.75	-642.2	-618.01	-486.8	-399.12	-303.07
Comprehensive Income & Other	0.44	0.47	0.45	0.55	0.4	0.45
Total Common Equity	31.88	53.55	-28.97	92.08	103.9	184.73
Shareholders' Equity	31.88	53.55	-28.97	92.08	103.9	184.73
Total Liabilities & Equity	66.33	88.53	70.09	151.53	146.69	235.37

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	3.5	5.25	8.38	11.14	12.57	14.46
Net Cash (Debt)	26.88	72.59	48.56	124.57	113.25	176.28
Net Cash Growth	-76.84%	49.48%	-61.01%	9.99%	-35.75%	-23.52%
Net Cash Per Share	2.58	7.34	7.75	48.59	66.31	110.57
Filing Date Shares Outstanding	6.24	6.19	6.11	3.03	1.72	1.71
Total Common Shares Outstanding	6.24	6.18	3.86	3	1.72	1.71
Working Capital	33.78	61.63	40.4	117.18	100.42	165.47
Book Value Per Share	5.11	8.67	-7.50	30.65	60.52	108.18
Tangible Book Value	31.88	53.55	-28.97	92.08	103.9	184.73
Tangible Book Value Per Share	5.11	8.67	-7.50	30.65	60.52	108.18
Machinery	8.38	8.32	8.04	7.91	8.28	7.48
Construction In Progress	-	-	0	0	0.02	0.02
Leasehold Improvements	6.26	6.26	6.1	6.1	6.09	5.94

SEC Filings: 10-K · 10-Q